Great arteries, as well as lungs and skin, contain elastic fibers as important components to maintain their physiological functions. Although recent studies have revealed that a glycoprotein fibulin-4 (FBLN4) is indispensable for the assembly of mature elastic fibers, it remains to be elucidated how FBLN4 takes part in elastogenesis. Here, we report a dose-dependent requirement for FBLN4 in the development of the elastic fibers in arteries, and a specific role of FBLN4 in recruiting the elastin-cross-linking enzyme, lysyl oxidase (LOX). Reduced expression of Fbln4, which was achieved with a smooth muscle-specific Cre-mediated gene deletion, caused arterial stiffness. Electron-microscopic examination revealed disorganized thick elastic laminae with aberrant deposition of elastin. Aneurysmal dilation of the ascending aorta was found when the Fbln4 expression level was reduced to an even lower level, whereas systemic Fbln4 null mice died perinatally from rupture of the diaphragm. We also found a specific interaction between FBLN4 and the propeptide of LOX, which efficiently promotes assembly of LOX onto tropoelastin. These data suggest a mechanism of elastogenesis, in which a sufficient amount of FBLN4 is essential for tethering LOX to tropoelastin to facilitate cross-linking.
Great arteries, as well as lungs and skin, contain elastic fibers as important components to maintain their physiological functions. Although recent studies have revealed that a glycoprotein fibulin-4 (FBLN4) is indispensable for the assembly of mature elastic fibers, it remains to be elucidated how FBLN4 takes part in elastogenesis. Here, we report a dose-dependent requirement for FBLN4 in the development of the elastic fibers in arteries, and a specific role of FBLN4 in recruiting the elastin-cross-linking enzyme, lysyl oxidase (LOX). Reduced expression of Fbln4, which was achieved with a smooth muscle-specific Cre-mediated gene deletion, caused arterial stiffness. Electron-microscopic examination revealed disorganized thick elastic laminae with aberrant deposition of elastin. Aneurysmal dilation of the ascending aorta was found when the Fbln4 expression level was reduced to an even lower level, whereas systemic Fbln4 null mice died perinatally from rupture of the diaphragm. We also found a specific interaction between FBLN4 and the propeptide of LOX, which efficiently promotes assembly of LOX onto tropoelastin. These data suggest a mechanism of elastogenesis, in which a sufficient amount of FBLN4 is essential for tethering LOX to tropoelastin to facilitate cross-linking.
development ͉ elastin ͉ extracellular matrix E lasticity is an important characteristic for many vital organs such as the great arteries, lungs, and skin (1) . To maintain their physiological function, these organs need to undergo repeated cycles of extension and contraction. However, aging leads to loss of elasticity in these organs, resulting in loose skin and pathological conditions such as aortic aneurysm, arteriosclerosis, and lung emphysema (2, 3) . Elasticity is provided by the abundant elastic fibers contained in these tissues. The major components of elastic fibers are polymerized elastin and microfibrils (1) . Microfibrils are thin filaments 10-15 nm in diameter, mainly composed of fibrillin-1 and fibrillin-2 (4, 5) . These filaments serve as a scaffold to assemble tropoelastin, i.e., elastin monomer (6) . Tropoelastin is a 60-to 70-kDa secreted protein and contains lysine-rich sequences (7) . In normal elastogenesis, it is proposed that tropoelastin monomers form small aggregates by self-assembly, a process called coacervation, and these aggregates are then transported onto microfibrils followed by cross-linking of lysine residues, catalyzed by lysyl oxidase (LOX), to form mature elastic fibers (8) .
Several other proteins, such as microfibril associated glycoproteins (MAGPs) (9, 10) , elastin microfibril interface located proteins (EMILINs) (11, 12) , fibronectin (13, 14) , and latent TGF-␤ binding proteins (LTBPs) (15, 16) , also contribute to elastogenesis. Fibulins (FBLNs) are proteins recently reported to have important roles in elastogenesis. So far, the FBLN family consists of seven members, which share tandem arrays of calcium-binding (cb)EGF-like domains and a conserved carboxy-terminal domain (17, 18) . Among these members, FBLN3, 4, and 5 are 50-to 60-kDa secreted proteins that share particularly high homology to each other (19) .
Recent studies using genetically engineered mice revealed that FBLN3, 4, and 5 are indispensable for normal elastogenesis. FBLN3 was identified as a protein overexpressed in fibroblasts derived from a patient with Werner syndrome (20) . Mutations in the human FBLN3 gene are associated with the eye diseases Doyne honeycomb retinal dystrophy and Malattia Leventinese (21) . Fbln3-deficient mice show defective elastogenesis mainly in connective tissue fascia, leading to inguinal hernias and protrusion of xiphoid process without obvious manifestation in the vascular system (22) . Developmental arteries and neural crest EGF-like protein (DANCE, also called FBLN5) is another member of the FBLN family, abundantly present in developing arteries (19, 23) . Dancedeficient mice show stiff and tortuous aortae, emphysematous lungs, and loose skin, indicating that DANCE has an essential role in elastogenesis (24, 25) . Our previous studies revealed that recombinant DANCE protein promotes elastic fiber assembly in serumfree cell culture by recruiting tropoelastin to microfibrils (26) . Mutations in the DANCE gene have been implicated in human diseases, i.e., age-related macular degeneration and cutis laxa syndrome (27) (28) (29) . FBLN4 was cloned as a new matrix protein from a melanoma cDNA library (30) . Recently, Fbln4-deficient mice were described (31) . These mice have tortuous aortae and emphysematous lungs, with severe disruption in elastic tissues. Although FBLN4 is suggested to be involved in some pathological conditions such as cutis laxa, aneurysm, and osteoarthritis (32, 33) , the role of FBLN4 in postnatal development has not been fully elucidated, because Fbln4 null mutations are perinatally lethal. The mechanism by which FBLN4 contributes to elastogenesis is not known, although elastin cross-links are largely lost in Fbln4-deficient mice (31) .
LOXs are copper-requiring amine oxidases that catalyze crosslinking of elastin molecules. They are composed of five members: LOX and LOX-like 1-4 (LOXL1-4) (34), among which LOX and LOXL1 are most similar and comprise a subfamily. They are secreted as inactive proenzymes, 50-kDa proLOX and 60-kDa proLOXL1, respectively, containing a glycosylated N-terminal propeptide domain followed by the catalytic domain. The propeptides of the proenzymes are eventually cleaved by proteases, such as bone morphogenic protein (BMP)1 and tolloid-like (TLL)1 (35, 36) , producing mature 32-kDa LOX or 31-kDa LOXL1. The propeptides of LOX and LOXL1 are reported to be required for targeting mature enzymes on elastic fibers (37) , but the precise mechanism has not been elucidated. Lox-deficient mice have large defects in their diaphragms, have markedly tortuous aortae with severely disrupted elastic laminae, and die perinatally (38, 39) .
To elucidate the precise role of FBLN4 in the development of elastic fibers in arteries, we generated mice harboring floxed Fbln4 alleles and crossed them with Sm22-Cre mice that express Cre recombinase in smooth muscle cells. The aortae of Fbln4 flox/flox Smϩ mice are stiff, and the elastic laminae are disorganized with aberrant deposition of elastin. Severe aneurysmal dilatation of the ascending aortae was found in Fbln4 flox/null Smϩ mice, showing a dose-dependent requirement for FBLN4 in aorta development. We also report a specific interaction between FBLN4 and the propeptide of LOX, which facilitates assembly of LOX on tropoelastin. These results imply that FBLN4 acts as an indispensible adaptor between proLOX and elastin to facilitate proper maturation of elastic fibers.
Results

Generation of Fbln4
Conditional Knockout Mice. Fbln4 conditional knockout mice were generated as described in Methods and in Fig.  S1 A. The Cre-loxP-mediated recombination generated the ''⌬Ex2'' allele, causing a frameshift and producing a stop codon in exon 3, resulting in a short peptide of 15-aa length after cleavage of the signal peptide (Fig. S1B) . Successfully targeted ES cells and F1 mice were identified by Southern blotting (Fig. S1 C and D, respectively) . Primer sequences used to amplify the probe are shown in Table S1 . The Fbln4 allele of knockout mice previously reported (31) will be designated hereafter as the ''null'' allele for clarity.
To confirm that ⌬Ex2 allele cannot produce functional FBLN4 protein, we monitored Fbln4 mRNA and FBLN4 protein levels in Fbln4 ⌬Ex2/⌬Ex2 mice. The expression of Fbln4 mRNA and FBLN4 protein were abolished in Fbln4 ⌬Ex2/⌬Ex2 mice ( Fig. 1; Fig. S2 A) . These mice died just after birth with severe diaphragmatic hernias ( Fig. S3 A and B) and tortuous aortae (Fig. S3C) . Elastica van Gieson (EVG) staining showed complete disarrangement of aortic elastic laminae and impaired development of distal airways ( Fig.  2A) . Transmission electron microscopy (TEM) showed that elastogenesis was abolished in the entire aorta in Fbln4 ⌬Ex2/⌬Ex2 mice, a phenotype identical to that of Fbln4 null/null mice (Fig. 2B) . These results indicate that deletion of exon 2 of Fbln4 extinguishes the expression of functional protein.
To investigate the tissue-specific role of FBLN4 in arteries, smooth muscle-specific conditional knockout mice were generated by crossing Fbln4 flox/ϩ mice with mice expressing Cre recombinase under control of the Smooth Muscle Protein 22␣ (Sm22␣, also known as Tagln) gene promoter (40) . The expression of Sm22␣ is detected in the dorsal aorta as early as in 9.5 days postcoitus (dpc) (41) . Examination at 14.5 dpc of indicator mice crossed with Sm22␣-Cre mice confirmed that the Cre recombinase is expressed in the entire layer of the developing aorta (Fig. S2B) . Western blotting of Fbln4 flox/flox Smϩ embryos at 16.5 dpc showed that the expression of FBLN4 protein was largely abolished in the aorta or umbilicus, whereas its expression level was comparable with wild type in the lung, skin, skeletal muscle, and kidney (Fig. S2C) cending aorta, from the aortic root to just distal to the branching point of the brachiocephalic artery ( Fig. S4 A and B) . There was no aortic stenosis. Left ventricular hypertrophy was present in Fbln4 flox/null Smϩ mice, which may be due to aortic insufficiency, because regurgitation of the contrast media into the left ventricle was observed (Fig. S4C) .
To investigate the development of elastic tissues in the aorta, specimens of descending aortae were examined with TEM at postnatal days (P)0, P14, 12 weeks, and 10 months (Fig. 3B) . The aortic laminae of Fbln4 flox/null Smϩ mice were already disrupted at P0, although continuous thin layers of elastic lamina were formed in Fbln4 flox/flox Smϩ mice and control mice. At P14, the elastic laminae of both Fbln4 flox/null Smϩ and Fbln4 flox/flox Smϩ mice were disrupted; they were fragmented and of spongy appearance, and clumps of elastin were not integrated into compact lamellar structure. Thereafter, the laminae failed to develop properly, resulting in markedly fragmented and spongy elastic laminae with some elastin clumps scattered in interlaminar spaces. These findings were also observed in the ascending aortae (Fig. S4D) . The results from Fbln4 flox/flox Smϩ mice indicate that the residual (18.5%) expression of Fbln4 in arteries is sufficient for embryonic development of elastic laminae, but is insufficient to support the development of elastic laminae after birth. The results from Fbln4 flox/null Smϩ mice indicate that less (8.4%) expression of Fbln4 in the developing aorta not only falls short of organizing elastic laminae in embryogenesis, but also leads to ascending aortic aneurysm.
Impaired Elastic Properties of Aortae of Conditional Knockout Mice.
To assess the elasticity of these aortae, pressure-diameter relationships were investigated with ex vivo experiments of 12-week-old mice. The acquired curves of both Fbln4 flox/null Smϩ and Fbln4 flox/flox Smϩ mice were much steeper than those of control mice, indicating that these aortae are significantly less distensible ( Fig. 4 A and B) . The curves for control mice did not differ significantly each other (Fig. 4C ). In the range of physiological pressure, i.e., 40-to 120-mm Hg, the slopes of the pressure-diameter curves for Fbln4 flox/null Smϩ and Fbln4 flox/flox Smϩ mice were significantly larger than those of the control groups (Fig. 4D ). These results indicate that disruption of Fbln4 leads not only to morphologically, but also to physiologically impaired aortic elastic laminae, resulting in significantly stiff aortae. (31), we hypothesized that FBLN4 may act on the expression or function of LOX, a cross-linking enzyme of elastin. The expression level of neither Lox mRNA nor LOX protein was affected in Fbln4 conditional knockout mice aortae (Fig. S5) . Therefore, we investigated the interaction of FBLN4 and LOX by in vitro binding assays. Myc-tagged LOX proteins were incubated with FLAG-tagged FBLN4 or DANCE proteins. Each mixture was subjected to immunoprecipitation with anti-FLAG antibody, and then, Myc-tagged LOX associated with the FLAG-tagged proteins were detected by Western blotting. This examination revealed that FBLN4 interacts with LOX, whereas DANCE does not (Fig. 5A) .
To identify the binding domain, FBLN4 protein was divided into three domains (N, M, and C; Fig. 5B ). An immunoprecipitation assay showed that only the mutant lacking the N-domain could not interact with Myc-tagged LOX (Fig. 5C , lane 2). To confirm the binding specificity, we performed immunoprecipitation experiments with truncated proteins. Consistent with the result with the deletion mutants, an assay using domain-only constructs of FBLN4 showed that only FLAG-tagged N-domain could interact with Myc-tagged LOX, whereas M-and C-domains could not (compare lane 2 with lanes 3 and 4 in Fig. 5D ). These results indicate that the N-terminal domain of FBLN4 specifically interacts with LOX. The immunoprecipitation assay using LOX truncated proteins also revealed that the propeptide region of LOX interacts with FBLN4, whereas mature LOX does not (Fig. 5E ). Taking all of these results into account, we conclude that FBLN4 interacts with the propeptide of LOX through its N terminus domain.
FBLN4 Colocalizes with LOX on Elastic Fibers.
To examine whether FBLN4 interacts with LOX in the course of elastic fiber assembly, we performed immunostaining of cultured human skin fibroblasts (HSFs) to visualize endogenously expressed FBLN4, LOX, and elastin. As shown in Fig. 6 A and B, FBLN4 colocalized both with LOX and elastin. Together with the direct binding of FBLN4 with LOX shown above and of FBLN4 with tropoelastin (31), these findings suggest that interaction of FBLN4 and LOX occurs during the process of elastic fiber assembly. Because both Fbln4 null mice and Lox null mice exhibit markedly decreased amount of crosslinked elastin (31, 38) , we reason that the direct interaction of these molecules have an important role in elastogenesis.
FBLN4 Tethers proLOX on Tropoelastin.
To investigate the role of FBLN4 and LOX interaction in elastogenesis, a solid phase binding assay was performed. Tropoelastin-coated plates were incubated with full-length LOX (proLOX) with or without FBLN4. As shown in Fig. 6C , proLOX could not bind tropoelastin in the absence of FBLN4. However, when FBLN4 was added into the reaction buffer, proLOX bound to the plate, which suggests that FBLN4 tethers proLOX on tropoelastin.
Discussion
In the present study, we generated smooth muscle-specific Fbln4 knockout mice, and found that a marked decrease (down to 18.5 Ϯ 6.3%) of Fbln4 expression in arteries of Fbln4 flox/flox Smϩ mice causes defective postnatal development of elastic laminae, but the residual expression of Fbln4 is sufficient for embryonic development of elastic laminae. Decreased expression of Fbln4 to an even lower level in Fbln4 flox/null Smϩ mice (8.4 Ϯ 2.7%) resulted in aberrant embryonic development of elastic laminae and aneurysm of ascending aortae. We also found that FBLN4 recruits proLOX on tropoelastin via interaction with the propeptide of LOX, indicating that FBLN4 acts to place LOX in the proximity of its substrate, tropoelastin. The interaction with LOX was not observed for DANCE, suggesting that each FBLN has a distinct role in elastogenesis.
Considering the complete disruption of elastic laminae in Fbln4 null/null (31) or Fbln4 ⌬Ex2/⌬Ex2 neonates, it is of interest that Fbln4 flox/flox Smϩ mice do not show impaired elastogenesis at P0, although Sm22␣-Cre is expressed at 14.5 dpc when aortic elastic laminae start to develop, and the expression of FBLN4 in the aorta is largely eliminated by P0. An explanation for this discrepancy is that a small amount of residual FBLN4 may be sufficient for the embryonic development of elastic laminae. Another possibility is that FBLN4 secreted from remote organs, such as lungs, kidneys, and skeletal muscles, may act on developing arteries in an endocrine manner. In either case, our results demonstrate the requirement for FBLN4 in postnatal development of elastic laminae. The amount of insoluble elastin in the aortae of our conditional knockout mice appeared to be comparable with those of control mice in electron micrographs. This finding suggests that a small amount of FBLN4 (8%) is sufficient for the elastin cross-link, but is insufficient for proper assembly of elastin to form compact layers.
Another genetically engineered mouse mutant with reduced expression of FBLN4 has been described (42) . Targeted disruption of the Mus81 gene, which is located adjacent to the Fbln4 gene, by insertion of a neo r cassette resulted in Fbln4 R/R mice with Fbln4 mRNA expression reduced to Ϸ25% in embryonic fibroblast and to Ϸ40% in adult aorta compared with wild-type controls. These mice show dilated ascending aortae and tortuous descending aortae by 10 days after birth, although the reduction of Fbln4 expression in aortae is much milder than in our Fbln4 flox/flox Smϩ mice. The systemic reduction of Fbln4 in tissues in Fbln4 R/R mice may account for the more severe phenotype than that of our mice. It is still possible that the disruption of the Mus81 gene influences the phenotype of Fbln4 R/R mice, because Mus81 is an endonuclease implicated in maintaining genetic stability, although Mus81 single knockout mice do not show gross abnormalities (43) . Hanada et al. (42) suggested a relationship between the increase of TGF␤ signaling and the development of aneurysm in Fbln4 R/R mice. Further investigation is required to clarify whether augmented TGF␤ signaling is involved in the aneurysm progression in our conditional knockout mice. Mutations of the human FBLN4 gene have been recently reported. A compound heterozygous FBLN4 mutant was recently described to show cutis laxa, aneurysm restricted to the ascending aorta, and tortuous arteries, with severe reduction of the tissue content of elastic fibers (44) . Another human FBLN4 missense mutation was reported to result in cutis laxa, vascular tortuosity, ascending aortic aneurysm, emphysema, and diaphragmatic hernia with underdeveloped elastic tissues (32) . These arterial symptoms found in humans are consistent with the phenotypes of our Fbln4 conditional knockout mice.
In elastic fiber assembly, LOX has a crucial role. It has been reported that the propeptide of LOX is required to direct LOX on elastic fibers in cell culture (37) . In this study, however, both the prodomain and mature catalytic domain interacted with tropoelastin as monitored by ligand blot and mammalian two-hybrid assays. Therefore, it was not clear why the propeptide, not the catalytic domain, is necessary for LOX deposition onto elastic fibers. In the present study, we found that the LOX propeptide, not its catalytic domain, specifically interacts with FBLN4 (Fig. 5E ). Solid-phase binding assays revealed that FBLN4 facilitates the deposition of proLOX on tropoelastin, whereas proLOX alone cannot deposit on tropoelastin (Fig. 6C) . From these data, together with our previous data showing direct binding of FBLN4 and tropoelastin (31), we propose a model for the role of FBLN4: FBLN4 recruits LOX to elastic fibers by tethering proLOX to tropoelastin; thus, facilitating tropoelastin cross-linking (Fig. 6D ). In this model, proLOX is cleaved to be activated in the vicinity of its substrate, tropoelastin, which may explain why active LOX are not scattered in the extracellular space to form unwanted cross-links. This model is further supported by previously reported findings that in Fbln4 null/null mice, desmosine content was reduced to 6% of wild-type mice, although the expression of LOX and elastin was not altered, indicating a requirement for FBLN4 in the proper cross-linking reaction (31) .
Recently, it was reported that full-length LOX interacts with FBLN4 and that fibrillin-1 inhibits the interaction of these proteins (45) . In this study, Choudhury et al. (45) also showed using BIAcore that interaction of FBLN4 and tropoelastin was enhanced in the presence of full-length LOX. These findings, together with our results, emphasize the importance of the ternary complex of FBLN4, LOX, and tropoelastin in the process of elastic fiber assembly.
Because there are many molecules involved in elastogenesis, we cannot exclude the possibility that the observed requirement for FBLN4 reflects the participation of other extracellular molecules. For example, as FBLN4 binds to DANCE (45), the reduced expression of FBLN4 may affect the function of DANCE. The larger requirement for FBLN4 in postnatal development may reflect the different expression pattern of LOX families during the pre and postnatal development. Further studies will be required to test these hypotheses.
In summary, we found that FBLN4 is required in the postnatal development of arterial elastic laminae, and the dose requirement of FBLN4 is larger in postnatal development than in embryogenesis. FBLN4 tethers LOX to tropoelastin through the interaction with the LOX propeptide, which illustrates a specific role for FBLN4 in promoting the proper maturation of elastic fibers. FBLN4 might be an agent to treat age-related pathologic conditions that are related to elastic fiber degradation, for example, aortic aneurysm.
Methods
Generation of Fbln4 Conditional Knockout Mice. The exon 2 of mouse Fbln4 was flanked by two loxP sequences inserted in intron 1 and 2. To generate vascular smooth muscle specific Fbln4 conditional knockout mice, Fbln4 flox/ϩ mice were crossed with transgenic mice expressing Cre recombinase under control of the Sm22␣ promoter (The Jackson Laboratory) (40, 41) . To generate systemically exon 2-deleted mice (⌬Ex2), Fbln4 flox/ϩ mice were crossed with Ayu-1 Cre knockin mice (46, 47) . For details, see SI Methods. All animals were maintained and all experiments were performed in accordance with the Regulation on Animal Experimentation at Kyoto University.
Tissue RNA Extraction and Quantitative PCR. Total RNA was extracted using TRIzol reagent (Invitrogen) and transcribed to cDNA with random hexamers using the SuperScript III First-Strand Synthesis System (Invitrogen). For quantitative PCR, the reaction was performed with a QuantiFAST SYBR Green PCR kit (QIAGEN), and the products were analyzed with the DNA Engine Opticon (BioRad). Expression levels of Gapdh transcripts were used to normalize the cDNA levels. Data are presented as means Ϯ SD of several independent experiments each performed in duplicate. Primer sequences used for quantitative PCR are provided in Table S2 .
Pressure-Diameter Relationship. The aortae were excised, and the aorta dimensions and the intraaortic pressure were simultaneously recorded as previously described (24) . Numbers of studied mice are indicated in each figure. The slope of Under normal condition, secreted tropoelastin coacervates to form small aggregates (i); FBLN4 tethers proLOX on these aggregates (ii); these ternary complexes deposit on microfibrills and the propeptide of proLOX is cleaved by BMP1 producing mature LOX (iii); tropoelastin monomers are cross-linked to each other by mature LOX to produce functional elastic laminae (iv). (Right) However, in the absence of FBLN4, tropoelastin molecules coacervate (i') but proLOX cannot assemble to the aggregates (ii'); therefore, LOX cannot cross-link tropoelastin aggregates effectively even though they may be cleaved into mature form (iii'); which leads to disorganized elastic laminae (iv'). SMCs, smooth muscle cells. each curve was calculated from the aortic dimension at 40-mm Hg and 120-mm Hg. For details, see SI Methods.
In Vitro Binding Assay. Recombinant Myc-LOX or Myc-FBLN4 proteins were mixed with a set of FLAG-tagged proteins, and each mixture was subjected to immunoprecipitation with anti-FLAG M2 affinity gel (Sigma) followed by SDS/ PAGE and Western blotting as described previously (26) . Expression vectors of truncated mutants were constructed by amplifying cDNA as a template. Primer sequences used for PCR are provided in Table S3 . For details, see SI Methods.
Immunocytochemistry. HSFs, which were taken from the facial skin of a 3-monthold baby, were kindly provided by M. Naito (Kyoto University). HSFs were cultured on microscope cover glasses (Fisherbrand) and were stained as previously described (26) . The primary antibodies used were anti-LOX (NB-100-2530; Novus Biologicals), anti-elastin (PR533; EPC), and anti-FBLN4 (9C10) antibodies. The secondary antibodies used were AlexaFluor 488-conjugated anti-rabbit and AlexaFluor 546-conjugated anti-mouse IgG antibodies (Invitrogen), followed by nuclear staining with Hoechst 33258 (Dojindo). For details, see SI Methods.
Solid-Phase Binding Assay. Solid-phase binding assays using purified tropoelastin were performed as described previously with some modifications (31) . As soluble ligands, conditioned media of HEK293T cells transfected with a mammalian expression vector encoding FLAG-tagged full length LOX were used. Conditioned media were harvested and concentrated 10-fold by ultrafiltration in Centricon Ultracel YM-10 (Millipore). The concentrated sample was serially diluted with Tris-buffered saline containing 2% skim milk with 2 mM CaCl 2, with or without 40 g/mL of recombinant FBLN4. These mixtures were used as ligands for the assay. Data are presented as means Ϯ SD of three independent experiments. For details, see SI Methods. The targeting vector was constructed by modifying bacterial artificial chromosome RP23-411F4 (Invitrogen) using defective prophage -Red recombineering system (1-3). The targeting vector was electroporated into C57BL/6 mouse ES cells (DS Pharma Biomedical) with Nucleofector system (Lonza). Positive clones were selected by incubating cells with 200 mM Geneticin (Invitrogen) for 5 days, and homologous recombination was confirmed by Southern blotting using Fbln4 specific probe indicated in Fig. S1 A. Successfully recombineered ES cells were injected into blastocysts from ICR strain mice by Unitech, and chimera mice were bred with C57BL/6 mice to generate F1 mice. Genotypes of F1 mice were confirmed by Southern blotting. Neo-cassette flanked by FRT was removed by crossing F1 with CAG-FLPe deleter mice kindly provided by S. Itohara (4).
Supporting Information
To generate systemically exon 2-deleted mice (⌬Ex2), Fbln4 flox/ϩ mice were crossed with Ayu-1 Cre knockin mice, which express Cre recombinase in multiple tissues, including germ line (5, 6) . Descendant Fbln4 ⌬Ex2/ϩ mice without Ayu-1 Cre allele were crossed each other to generate Fbln4 ⌬Ex2/⌬Ex2 mice. To generate vascular smooth muscle specific Fbln4 conditional knockout mice, Fbln4 flox/ϩ mice were further crossed with transgenic mice expressing Cre recombinase under Smooth Muscle Protein 22␣ (Sm22␣) promoter (The Jackson Laboratory) (7, 8) . To confirm the expression pattern of Cre recombinase, Sm22␣-Cre mice were crossed with Rosa26-lacZ reporter mice (ROSA26R; The Jackson Laboratory) (9) , and subjected to lacZ staining. Fbln4 null mice (10) and Dance null mice (11) are described elsewhere. All experiments were carried out on C57BL/6 background except for ROSA26R mice that were on mixed background. Southern Blotting. Genomic DNA samples were purified from tail biopsy specimens and digested with EcoRI. Southern blotting was performed using [ 32 P] dCTP labeled probe indicated in Fig.  S1 A. Primer sequences used to amplify the probe are shown in Table S1 .
LacZ Staining. Sm22␣-Cre mice were bred with ROSA26R mice, and embryos were dissected at 14.5 days postcoitus (dpc). Tissues were fixed with 1% formaldehyde, 0.2% glutaraldehyde, 0.02% Nonidet P-40 in PBS with 2 mM MgCl 2 , and were embedded in Tissue-Tek OCT compound (Sakura Finetechnical). Sections were then stained as previously described (12, 13) , by incubating at room temperature for 140 min in 1 mg/mL X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 0.02% Nonidet P-40, 0.01% sodium deoxycholate in PBS with 2 mM MgCl 2 .
Tissue Extraction and Western Blotting. Proteins were extracted from aorta tissues with 8 M urea solution. Neonatal or embryonic tissues were homogenized in PBS, and supernatants were collected. Protein samples of the same amount were subjected to SDS/PAGE (Invitrogen), followed by Western blotting. Anti-FBLN4 polyclonal antibody (109), anti-LOX polyclonal antibody (ab31238; Abcam), or anti-␤ actin monoclonal antibody (AC-15; Sigma) was used as a primary antibody, horseradish peroxidaseconjugated anti-rabbit or anti-mouse IgG antibody (sc2054 and sc2055, respectively; Santa Cruz Biotechnology) was used as a secondary antibody. Signals were detected using Western Lightning Plus Chemiluminescence Reagent (Perkin-Elmer). Rabbit polyclonal anti-FBLN4 antibody (109) was raised by SigmaGenosys against KLH-conjugated polypeptide CPQGYEPD-EQES, which corresponds to amino acids 109-120 of mouse FBLN4 protein.
Histological Examination. For EVG staining, tissues were fixed with 3.7% formaldehyde, and embedded in paraffin blocks. Sections were stained according to standard procedures, and were observed with an Axioskop 2 plus microscope equipped with an Axiocam digital camera (Carl Zeiss).
For transmission electron microscopy (TEM), aorta tissues were fixed with 2% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M cacodylate buffer with 0.025% CaCl 2 . After several washes with 0.05 M cacodylate buffer containing 0.2 M sucrose, specimens were postfixed in 0.1% osmium tetroxide in 0.05 M cacodylate and 0.2 M sucrose buffer, were embedded in either Epon812 (TAAB Laboratories Equipment) or Quetol-651 (Nisshin EM). Thin sections were cut on a Reichert-Nissei UL-TRACUT S ultramicrotome (Leica) and treated for 1 h with solution containing 5.7 mg/mL tannic acid (Nacalai Tesque) and 14.3 mg/mL p-nitrophenol (Wako Pure Chemical). Sections were counterstained with uranyl acetate followed by lead citrate, and examined with JEM-1400A TEM (JEOL).
Aortography. Mice were anesthetized with pentobarbital (DS Pharma Biomedical), and cannulated in the right carotid arteries. Contrast medium (Iopamidol; Bayer Schering Pharma) was injected in the aorta through the catheter, and the aortograph was observed with an X-ray imaging system OEC 9800 Plus (GE Healthcare) through a left anterior oblique view, to view the entire aortic arch.
Pressure-Diameter Relationship. The aortae were excised and observed as previously described (11) . The dimension of aorta that was measured at proximal portion of the descending aorta with a digital image processor CV-2000 (Keyence) and the intraaortic pressure measured with a transducer were simultaneously recorded using a Powerlab data acquisition system (AD Instruments). Numbers of studied mice are indicated in each figure. Each aorta was measured for three times and averaged, and the curves were obtained by plotting mean Ϯ SD for all studied mice. Slope of each curve was calculated from the aortic dimension at 40-mm Hg and 120-mm Hg. Statistical analyses were performed with unpaired t test. P Ͻ 0.05 was considered to be significant.
In Vitro Binding Assay. Full-length cDNA of human FBLN4 was cloned by reverse transcription PCR from human skin fibroblast (HSF) RNA. Full-length cDNA of human LOX was cloned by PCR using IMAGE cDNA clone 1681885 as a template. Human full-length DANCE cDNA is previously described (14) .
Expression vector pEF6/V5 (Invitrogen) was modified to attach a preprotrypsin signal sequence followed by a FLAG-tag or a Myc-tag, and a His 6 tag to the N terminus of its inserted protein (named pEF6/FLAG and pEF6/Myc, respectively). FBLN4 FL (nucleotides 276-1526) and LOX FL (nucleotides 439-1629) cDNA were subcloned into both vectors. The FBLN4 ⌬N (nucleotides 561-1526), ⌬C (nucleotides 276-1169), N (nucleotides 276-560), M (nucleotides 561-1169), C (nucleotides 1170-1526), LOX pro (nucleotides 439-879), LOX mat (nucleotides 880-1629), and DANCE cDNAs were amplified by PCR, and subcloned into pEF6/FLAG. FBLN4 ⌬M (nucleotides 276-560, 1170-1526) cDNA fragment was amplified by inverse PCR, followed by self-ligation. Human FBLN4 and LOX cDNA sequences are numbered according to GenBank accession no. NM016938 and NM002317, respectively. All constructs were confirmed by sequencing (ABI Prism 3100). Primer sequences used for PCR are provided in Table S3 .
HEK293T cells were maintained in DMEM (GIBCO) supplemented with 2 mM glutamine, 100 units/100 g/mL penicillin/ streptomycin, and 10% FBS at 37°C in 5% CO 2 . HEK293T cells were transiently transfected with expression vectors of FLAGtagged protein or a mock vector using Lipofectamine Reagent (Invitrogen). Expression vectors for Myc-tagged proteins were also independently transfected into 293T cells. Transfected cells were cultured in serum-free DMEM/F12 (Sigma) for 48 h, and then, the cell lysates and the conditioned media were harvested and mixed. After incubation of Myc-tagged proteins with a set of FLAG-tagged proteins, each mixture was subjected to immunoprecipitation with anti-FLAG M2 affinity gel (Sigma) followed by SDS/PAGE and Western blotting as described previously (15) .
Immunocytochemistry. HSFs were cultured on microscope cover glasses (Fisherbrand), in DMEM/F12 (Sigma) supplemented with 2 mM glutamine, 100 units/100 g/mL penicillin/ streptomycin, and 10% FBS at 37°C in 5% CO 2 , and were stained as previously described (15) . The primary antibodies used were anti-LOX polyclonal (NB-100-2530; Novus Biologicals), anti-elastin polyclonal (PR533; EPC), and anti-FBLN4 monoclonal (9C10) antibodies. The secondary antibodies used were AlexaFluor 488-conjugated anti-rabbit and AlexaFluor 546-conjugated anti-mouse IgG antibodies (Invitrogen), followed by nuclear staining with Hoechst 33258 (Dojindo). Antibodies were diluted in Can Get Signal immunostain solution (TOYOBO) according to the manufacturer's instruction. Stained cells were examined using a Nikon Digital Eclipse C1si Laser Confocal system. Anti-FBLN4 monoclonal antibody (9C10) was raised against recombinant full-length human FBLN4 by TransGenic.
Solid-Phase Binding Assay. HEK293T cells were transfected with pEF6/Myc-human FBLN4 with Lipofectamine Reagent (Invitrogen), according to the manufacturer's protocol. Stably transfected cells were selected with Blasticidin (Invitrogen), and recombinant FBLN4 was purified from the serum-free conditioned medium of stable lines with TALON His-Tag Purification resins (Takara). The purity of the protein was confirmed by Coomassie blue staining of a SDS/PAGE gel, and the protein concentration was determined with Coomassie Plus Reagent (Pierce).
Solid-phase binding assay using purified tropoelastin was performed as described previously with some modifications (10) . As soluble ligands, conditioned media of 293T cells transfected with pEF6/FLAG-LOX FL were used. Cells were transfected with the plasmid as described above, and were cultured in serum-free DMEM/F12 (Sigma) for 48 h. The conditioned medium was harvested and was concentrated 10-fold by ultrafiltration in Centricon Ultracel YM-10 (Millipore). The concentrated sample was serially diluted with Tris-buffered saline at a final concentration of 2% skim milk with 2 mM CaCl 2 , with or without 40 g/mL of recombinant FBLN4. These mixtures were used as ligands for the assay. Anti-FLAG M2 antibody (Sigma) and horseradish peroxidase-conjugated anti-mouse IgG antibody (Santa Cruz) was used as a primary antibody and a secondary antibody, respectively. A color reaction assay was performed with Substrate Reagent Pack (R&D), followed by optic density measurement at 450 nm. Data are presented as means Ϯ SD of three independent experiments. 
